ALGERIA: Advancing Regulatory Digitalization in the Medical Device Sector

In an effort to enhance efficiency and transparency, the Algerian National Agency for Pharmaceutical Products (ANPP) has introduced key digitalization initiatives for the regulatory processes related to medical device authorizations.

Implementation of an Online Appointment System

Effective February 2, 2025, all applications for approval, modification, renewal, and transfer of medical device authorizations must be submitted through a newly established online appointment system. Each establishment will be allowed a maximum of three (03) appointments per week, with each appointment corresponding to the submission of one dossier. Appointment confirmations will be sent via email, and cancellations must be notified at least 48 hours in advance via rdvdm.anpp@gmail.com. The online system can be accessed at: https://lnkd.in/du2HbD5e.

Updated Submission Forms Available Online

To further streamline the approval process, ANPP has updated the application form and submission receipt for medical device authorization requests. These documents are now available on the official ANPP website: www.anpp.dz.

These initiatives mark a significant step toward the digital transformation of Algeria’s pharmaceutical regulatory sector. By implementing these measures, the ANPP aims to ensure greater accessibility, efficiency, and compliance for all establishments involved. The strict application of these directives will be essential for a smooth and effective transition.

You can view the published note directly via this link : https://anpp.dz/wp-admin/admin-ajax.php?juwpfisadmin=false&action=wpfd&task=file.download&wpfd_category_id=146&wpfd_file_id=20182&token=&preview=